Guangzhou Women And Children's Medical Center
Clinical trials sponsored by Guangzhou Women And Children's Medical Center, explained in plain language.
-
New drug YOLT-204 aims to reduce transfusions in blood disorders
Disease control Not yet recruitingThis early-phase trial will test a single dose of a new drug called YOLT-204 in 18 children and teens with transfusion-dependent β-thalassemia or sickle cell disease. The goal is to see if it is safe and can raise fetal hemoglobin levels enough to reduce the need for blood transf…
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New study aims to predict deadly gut disease in preterm infants
Knowledge-focused Not yet recruitingThis study aims to create an early warning system for necrotizing enterocolitis (NEC), a severe gut emergency in preterm infants. Researchers will analyze genetic and immune markers from 1,050 babies born before 32 weeks to identify those at highest risk. The goal is to improve e…
Sponsor: Guangzhou Women and Children's Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC